ContractLicense and Supply Agreement • May 5th, 2020 • Delaware
Contract Type FiledMay 5th, 2020 Jurisdiction<DOCUMENT> <TYPE>EX-10.4 <SEQUENCE>3 <FILENAME>v91776exv10w4.txt <DESCRIPTION>EXHIBIT 10.4 <TEXT> <PAGE> Exhibit 10.4 *Certain confidential information contained in this document, marked by brackets, has been omitted and filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. LICENSE AND SUPPLY AGREEMENT This LICENSE AND SUPPLY AGREEMENT (the "Agreement") is entered into as of May 27, 2003 (the "Effective Date") between CORIXA CORPORATION, a Delaware corporation, with its principal place of business at 1124 Columbia Street, Suite 200, Seattle, WA 98104, U.S.A. and its subsidiary Coulter Pharmaceutical, Inc. (referred to individually as "Corixa Corporation" and "Coulter Pharmaceutical", respectively, and collectively as "Corixa"), and GLAXOSMITHKLINE INC., a corporation amalgamated and continued under the laws of Canada, with its principal place of business at 7333 Mississauga Road North, Mississauga, Ontario, Canada L